During the past decade, Centre for Experimental Cancer Medicine (CECM) conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Centre for Experimental Cancer Medicine (CECM)" are "Glioma" (1 trials), "Hepatocellular Carcinoma" (1 trials), "Mesothelioma" (1 trials), "Non-squamous Non-small Cell Lung Carcinoma" (1 trials) and "Peritoneal Mesothelioma Malignant Advanced" (1 trials). Many other conditions were trialed in "Centre for Experimental Cancer Medicine (CECM)" in a lesser frequency.

Most popular intervention types in "Centre for Experimental Cancer Medicine (CECM)" are "Drug" (2 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "ADI-PEG 20" (1 trials), "ADI-PEG 20 plus Pem Cis" (1 trials) and "Placebo plus Pem Cis" (1 trials). Other intervention names were less common.

The vast majority of trials in "Centre for Experimental Cancer Medicine (CECM)" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Centre for Experimental Cancer Medicine (CECM)". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Centre for Experimental Cancer Medicine (CECM), undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Centre for Experimental Cancer Medicine (CECM), 1 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".